Patents by Inventor Frank Sievert

Frank Sievert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB
    Publication number: 20150246043
    Abstract: The invention essentially relates to oral dosage forms comprising a JAK kinase inhibitor, preferably Ruxolitinib, suitable for modified release, and processes of preparing such oral dosage forms.
    Type: Application
    Filed: July 25, 2013
    Publication date: September 3, 2015
    Inventors: Ralph Stefan, Frank Sievert, Katrin Rimkus
  • Oral Dosage Forms for Modified Release Comprising Tasocitinib
    Publication number: 20130344149
    Abstract: The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms.
    Type: Application
    Filed: January 26, 2012
    Publication date: December 26, 2013
    Applicant: RATIOPHARM GMBH
    Inventors: Ralph Stefan, Frank Sievert
  • ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR
    Publication number: 20120195966
    Abstract: The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms.
    Type: Application
    Filed: January 27, 2012
    Publication date: August 2, 2012
    Inventors: Frank SIEVERT, Ralph STEFAN
  • Lyophilized emulsion containing an active substance
    Patent number: 5882684
    Abstract: The invention concerns a freeze-dried emulsion composition containing an active substance and which can be reconstituted using water to give the original emulsion, plus a method for producing the freeze-dried composition. The reconstituted emulsion is suitable for parenteral use.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: March 16, 1999
    Assignee: Schwarz Pharma AG
    Inventors: Andreas Schutz, Hans-Jurgen Mika, Frank Sievert, Bernard Emschermann
  • PGE.sub.1 emulsion composition kit
    Patent number: 5681855
    Abstract: The invention concerns a kit for the preparation of an emulsion containing prostaglandin E.sub.1, a method of preparing the emulsion and a method of preparing the emulsion composition contained in the kit. The emulsion prepared using this kit is suitable for parenteral application.
    Type: Grant
    Filed: September 21, 1995
    Date of Patent: October 28, 1997
    Assignee: Schwarz Pharma AG
    Inventors: Andreas Schutz, Hans-Jurgen Mika, Frank Sievert
  • Lyophilized emulsion containing an active substance
    Patent number: 5612058
    Abstract: The invention relates to a lyophilized emulsion composition which contains an active substance and which can be redispersed with water to give the original emulsion, and to a process for the preparation thereof.The redispersed emulsion is suitable for parenteral use.
    Type: Grant
    Filed: June 23, 1995
    Date of Patent: March 18, 1997
    Assignee: Schwarz Pharma AG
    Inventors: Andreas Schutz, Hans-Jurgen Mika, Frank Sievert, Bernhard Emschermann